{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-112904","form_type":"8-K","ticker":"KALV","cik":"0001348911","company_name":"KalVista Pharmaceuticals, Inc.","filed_at":"2024-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.234820+00:00","generated_at":"2026-05-30T19:54:21.681187+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"KalVista shareholders elect directors, ratify auditor, approve say-on-pay at 2024 annual meeting","bullets":["William Fairey and Nancy Stuart elected as Class III directors with 30.2M and 19.3M votes 'For', respectively; Stuart faced 11.7M votes 'Against'.","Deloitte & Touche ratified as independent auditor for FY ending April 30, 2025 with 39.3M votes 'For'.","Advisory say-on-pay proposal approved with 26.6M 'For', 4.5M 'Against'.","Broker non-votes of 8.3M shares recorded for director election and say-on-pay proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-112904","json":"https://secwatch.observer/filing/0000950170-24-112904.json","markdown":"https://secwatch.observer/filing/0000950170-24-112904.md","text":"https://secwatch.observer/filing/0000950170-24-112904.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348911/000095017024112904/0000950170-24-112904-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348911/000095017024112904/kalv-20241003.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:54:21.681187+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}